Literature DB >> 15124887

Cardiogenic hypertrophic osteopathy in a dog with a right-to-left shunting patent ductus arteriosus.

Timothy P Anderson1, Mark C Walker, Robert L Goring.   

Abstract

A 5-year-old castrated male Shetland Sheepdog was examined because of progressive bilateral hind limb thickening. Cyanosis of the preputial mucous membranes was evident, whereas the oral mucous membranes had a normal color. A well-structured, palisade-like periosteal reaction with no underlying bone destruction was evident on radiographs of the hind limbs. The radiographic changes were consistent with hypertrophic osteopathy (HO). Severe right-sided cardiomegaly was seen on thoracic radiographs, and a diagnosis of patent ductus arteriosus with right-to-left shunting was made by means of echocardiography and contrast echoaortography. The cyanotic heart disease was believed to be the cause of the HO. Hypertrophic osteopathy has been associated with a number of diseases in animals and humans. In humans, congenital heart defects that cause cyanosis are among the most common causes of HO.

Entities:  

Mesh:

Year:  2004        PMID: 15124887     DOI: 10.2460/javma.2004.224.1464

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Paraneoplastic hypertrophic osteopathy in 30 dogs.

Authors:  S S Withers; E G Johnson; W T N Culp; C O Rodriguez; K A Skorupski; R B Rebhun
Journal:  Vet Comp Oncol       Date:  2013-03-14       Impact factor: 2.613

2.  Renal adenocarcinoma associated with hypertrophic osteopathy in a cat.

Authors:  Sarah Elhamiani Khatat; Rosario Vallefuoco; Meryem El Mrini; Morgane Canonne-Guibert; Dan Rosenberg
Journal:  JFMS Open Rep       Date:  2020-11-22

3.  Hypertrophic osteopathy in a cat with cardiac interventricular septal defect.

Authors:  Felipe Auatt Batista de Sousa; Matheus Viezzer Bianchi; Paula Augusto Taunde; Marcele Bettim Bandinelli; Rochana Rodrigues Fett; David Driemeier; Saulo Petinatti Pavarini
Journal:  J Vet Sci       Date:  2019-09       Impact factor: 1.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.